
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[BDTX] Black Diamond Therapeutics Inc - Debt / Capital
Data updated 2023-Jun-24 (Saturday)Note: Detailed Statistics for Debt / Capital in Balance Sheet for Black Diamond Therapeutics Inc [NASDAQ:BDTX] with frequency distribution chart that analyze trends & history . Debt to Capital is a leverage ratio calculated as Total Liabilities / (Total Liabilities + Total Shareholder Equity). Debt to Equity Ratio measures financial risk considering proportion of debt that is being used to operate business. High Debt / Capital implies higher risk. View Balance Sheet for broader context
Share
Quarterly Debt / Capital values for Black Diamond Therapeutics Inc are rounded to enhance readability
2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | 2021-Dec | |
---|---|---|---|---|---|---|
Debt / Capital | 27.6% | 26.0% | 26.2% | 23.4% | 21.4% | 20.9% |
Sequential Quarter Growth | +6.2% | -0.7% | +11.9% | +9.3% | +2.2% | +3.9% |
Quarter-on Quarter Growth | +29.0% | +24.2% | +29.9% | +82.6% | +106.0% | +214.4% |
Annual Debt / Capital values for Black Diamond Therapeutics Inc are rounded to enhance readability
2022-Dec | 2021-Dec | 2021-Jan | 2020-Jan | 2019-Jan | 2018-Jan | |
---|---|---|---|---|---|---|
Debt / Capital | 26.0% | 20.9% | 20.9% | 6.7% | 129.8% | 130.0% |
Year-on-Year Growth | +24.2% | 0.0% | +214.4% | -94.9% | -0.2% | |
2-yr CAGR | +11.4% | +77.3% | -59.9% | -77.4% | ||
3-yr CAGR | +57.5% | -45.6% | -45.6% | |||
4-yr CAGR | -33.1% | -36.7% | ||||
5-yr CAGR | -27.5% |
Frequency distribution of quarterly Debt / Capital values from 2018-Dec-31 grouped into buckets. Latest Debt / Capital value is 27.6 as of 2023-Mar-31
Subsequent stock performance post earnings date till next announcement for Black Diamond Therapeutics Inc mapped with quarterly Debt / Capital values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Debt / Capital above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Black Diamond Therapeutics Inc with subsequent post-earnings performance given Debt / Capital values. Analysis uses quarterly data and subsequent relative performance benchmarked to S&P 500 index. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (relative perf.) | Outperform (relative perf.) | |
---|---|---|
Debt / Capital - Low | 64% | 36% |
Debt / Capital - Medium | 54% | 46% |
Debt / Capital - High | 54% | 46% |
Debt / Capital (Sequential growth %) - Low | 44% | 56% |
Debt / Capital (Sequential growth %) - Medium | 54% | 46% |
Debt / Capital (Sequential growth %) - High | 78% | 22% |
Debt / Capital (QoQ growth %) - Low | 28% | 72% |
Debt / Capital (QoQ growth %) - Medium | 78% | 22% |
Debt / Capital (QoQ growth %) - High | 70% | 30% |
Related to Black Diamond Therapeutics Inc
Information for Black Diamond Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Mar-14 on Google
SEC Reports : Quarterly reports around 2025-Mar-14 on SEC Edgar
Compare Black Diamond Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Black Diamond Therapeutics Inc
Industry : Biotechnology industry performance which includes Black Diamond Therapeutics Inc